M-J Milloy Selected Research

Therapeutics

3/2024	Denial of prescription pain medication among people who use drugs in Vancouver, Canada.
12/2022	Inability to contact opioid agonist therapy prescribers during the COVID-19 pandemic in a Canadian setting: a cross-sectional analysis among people on opioid agonist therapy.
6/2022	Assessing the Temporality Between Transitions onto Opioid Agonist Therapy and Engagement with Antiretroviral Therapy in a Cohort of HIV-Positive People Who Use Opioids Daily.
1/2022	Low awareness of risk mitigation prescribing in response to dual crises of COVID-19 and overdose deaths among people who use unregulated drugs in Vancouver, Canada.
1/2021	Trajectories of Retention in Opioid Agonist Therapy and Overdose Risk During a Community-Wide Overdose Epidemic in a Canadian Setting.
1/2021	The relationship between opioid agonist therapy satisfaction and fentanyl exposure in a Canadian setting.
1/2020	Changes in substance use in relation to opioid agonist therapy among people who use drugs in a Canadian setting.
1/2020	Trajectories of retention in opioid agonist therapy in a Canadian setting.
1/2020	Temporal changes in non-fatal opioid overdose patterns among people who use drugs in a Canadian setting.
12/2019	Willingness to take buprenorphine/naloxone among people who use opioids in Vancouver, Canada.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M-J Milloy Research Topics

Disease

21	Opioid-Related Disorders (Opiate Addiction) 01/2023 - 07/2015
19	Substance-Related Disorders (Drug Abuse) 10/2023 - 01/2018
15	Acquired Immunodeficiency Syndrome (AIDS) 07/2018 - 01/2012
10	Pain (Aches) 03/2024 - 09/2015
10	HIV Infections (HIV Infection) 05/2023 - 08/2012
9	Opiate Overdose 12/2021 - 01/2018
8	HIV Seropositivity 10/2023 - 06/2012
7	Chronic Pain 01/2023 - 09/2015
4	COVID-19 10/2023 - 12/2022
4	Infections 01/2019 - 08/2014
3	Hepatitis C 01/2019 - 01/2016
2	Mental Disorders (Mental Disorder) 05/2023 - 09/2015
2	Drug-Related Side Effects and Adverse Reactions 01/2023 - 01/2023
2	Disease Progression 06/2022 - 08/2014
1	Frailty 01/2023
1	Poisoning 12/2022
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2020
1	Drug Overdose 01/2020
1	Soft Tissue Infections 01/2019
1	Liver Diseases (Liver Disease) 01/2018
1	Major Depressive Disorder (Major Depressive Disorders) 01/2018
1	Alcoholism (Alcohol Abuse) 01/2018
1	Viremia 03/2016
1	Marijuana Use 09/2015
1	Sexual Trauma 06/2011

Drug/Important Bio-Agent (IBA)

33	Opioid Analgesics (Opioids)IBA 03/2024 - 09/2015
26	Illicit Drugs (Recreational Drugs)IBA 01/2023 - 06/2011
17	Methadone (Dolophine)FDA LinkGeneric 06/2023 - 06/2012
9	Fentanyl (Sublimaze)FDA LinkGeneric 10/2023 - 01/2018
7	Heroin (Diamorphine)IBA 03/2024 - 01/2014
7	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2023 - 09/2015
5	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2023 - 01/2014
3	CannabinoidsIBA 08/2021 - 03/2015
3	Antiviral Agents (Antivirals)IBA 01/2019 - 03/2015
2	COVID-19 VaccinesIBA 10/2023 - 10/2023
2	BenzodiazepinesIBA 11/2021 - 01/2016
2	Cocaine (Cocaine HCl)IBA 11/2019 - 01/2014
2	Viral RNAIBA 01/2019 - 08/2014
2	InterferonsIBA 01/2019 - 10/2017
1	VaccinesIBA 10/2023
1	Naloxone Drug Combination Buprenorphine FDA Link 06/2023
1	Therapeutic UsesIBA 01/2023
1	N-nitrosoiminodiacetic acidIBA 12/2022
1	Oxycodone (Oxycontin)FDA LinkGeneric 11/2022
1	Hallucinogens (Psychedelics)IBA 01/2022
1	Medical MarijuanaIBA 08/2021
1	Reverse Transcriptase InhibitorsIBA 09/2017
1	RNA (Ribonucleic Acid)IBA 01/2017
1	Pain-FreeIBA 12/2016
1	Analgesics (Analgesic Drugs)IBA 09/2015
1	Codon (Codons)IBA 08/2014

Therapy/Procedure

23	Therapeutics 03/2024 - 01/2015
4	Art Therapy 06/2022 - 01/2015
4	Highly Active Antiretroviral Therapy (HAART) 01/2018 - 08/2012
2	Injections 01/2019 - 01/2018
1	Pain Management 05/2023
1	Time-to-Treatment 01/2023
1	Dental Care 11/2021
1	Drug Therapy (Chemotherapy) 01/2021
1	Aftercare (After-Treatment) 01/2020
1	Condoms (Condom) 12/2019
1	Opiate Substitution Treatment 03/2016